Autopsy report · NCT04141371

Molar Sodium Lactate Filling in Severe Meningeal Hemorrhage

“The treatments are no longer available.”

The sponsor’s own words in the registry.

Life of this trial

• Registered 2 years 4 months before it started.
• Ran for about 2 years 4 months before it stopped.
• 3 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Phase 3

Sponsor

Centre Hospitalier Universitaire de Nice

Sponsor type

University, hospital or other

Conditions

Subarachnoid Hemorrhage, Aneurysmal

Interventions

Molar Sodium Lactate; physiological serum

Participants

3

Sites

3

Countries

France

Trials that died the same way

• Giant Cell Arteritis and Anakinra Trial
  “experimental treatment no longer available” (68% match in meaning)
• Oblimersen Sodium & Combination Chemotherapy in Treating Patients With Newly Diagnosed Diffuse Large B-Cell Lymphoma
  “Manufacturer is no longer making the drug.” (65% match in meaning)
• Developmental Correlates and Hormone Therapy Effects in Gender Dysphoria
  “the patients are now followed in another hospital. The study is discontinued” (65% match in meaning)
• Evaluation of MST-188 in Acute Lower Limb Ischemia
  “Program discontinued to persue alternate indications.” (64% match in meaning)
• Phase II Study of Intraventricular Methotrexate in Children With Recurrent or Progressive Malignant Brain Tumors
  “Lack of additional funding; patients (3) no longer receiving intervention.” (63% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.